{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:40:16Z","timestamp":1774939216061,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It is desirable that young women with primary ovarian failure achieve normal peak bone mass to reduce the subsequent risk of osteoporosis, and that there are management strategies to replace bone that is already lost. While estrogen (E2) is generally considered to prevent bone loss by suppressing bone resorption, it is now recognized that estrogen also exerts an anabolic effect on the human skeleton. In this study, we tested whether estrogen could increase bone mass in women with primary ovarian failure. We studied the mechanism underlying this by analyzing biochemical markers of bone turnover and iliac crest biopsy specimens obtained before and 3 years after E2 replacement. Twenty-one women with Turner's syndrome, aged 20-40 years, were studied. The T scores of bone mineral density at lumbar spine and proximal femur at baseline were \u22121.4 and -1.1, respectively. Hormone replacement was given as subcutaneous E2 implants (50 mg every 6 months) with oral medroxy progesterone. Serum E2 levels increased incrementally from 87.5 pM at baseline to 323, 506, 647, and 713 pM after 6 months and 1, 2, and 3 years of hormone replacement therapy (HRT), respectively. The bone mineral density at the lumbar spine and proximal femur increased after 3 years to T scores of -0.2 and -0.4, respectively. The cancellous bone volume increased significantly from 13.4% to 18.8%. There was a decrease in activation frequency, but the active formation period was increased by HRT. There was a significant increase in the wall thickness from 33.4 \u03bcm at baseline to 40.9 \u03bcm after 3 years of HRT, reflecting an increase in bone formed at individual remodeling units. Although there was an early increase in biochemical markers of bone formation, these declined thereafter. Our results show that estrogen is capable of exerting an anabolic effect in the skeleton of young women with Turner's syndrome and low bone mass.<\/jats:p>","DOI":"10.1359\/jbmr.2003.18.5.925","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T22:59:46Z","timestamp":1146092386000},"page":"925-932","source":"Crossref","is-referenced-by-count":50,"title":["A Longitudinal Study of the Effect of Subcutaneous Estrogen Replacement on Bone in Young Women With Turner's Syndrome"],"prefix":"10.1093","volume":"18","author":[{"given":"Gautam","family":"Khastgir","sequence":"first","affiliation":[{"name":"Department of Gynaecology, Chelsea and Westminster Hospital, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John WW","family":"Studd","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Chelsea and Westminster Hospital, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon W","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, St George's Hospital Medical School, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Charing Cross Hospital, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshid","family":"Alaghband-Zadeh","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Charing Cross Hospital, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade WM","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, St George's Hospital Medical School, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019142650900_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jmg.19.2.100","article-title":"Bone demineralisation in patients with Turner's syndrome","volume":"19","author":"Smith","year":"1982","journal-title":"J Med Genet"},{"key":"2024013019142650900_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02565125","article-title":"Skeletal size and bone mineral content in Turner's syndrome: Relation to karyotype, estrogen treatment, physical fitness and bone turnover","volume":"49","author":"Naeraa","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"2024013019142650900_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF02411296","article-title":"Skeletal demineralization in Turner's syndrome","volume":"34","author":"Shore","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"2024013019142650900_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-197311000-00004","article-title":"Orthopedic aspects of the XO (Turner's) syndrome","volume":"97","author":"Beals","year":"1973","journal-title":"Clin Orthop"},{"key":"2024013019142650900_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/bmj.301.6755.790","article-title":"Bone mineral loss in young women with amenorrhea","volume":"301","author":"Davies","year":"1990","journal-title":"BMJ"},{"key":"2024013019142650900_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2265.1995.tb00544.x","article-title":"Osteoporosis in Turner's syndrome and other forms of primary amenorrhea","volume":"43","author":"Davies","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013019142650900_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.0.1320047","article-title":"Bone mineral density in middle-aged women with Turner's syndrome","volume":"132","author":"Sylv\u00e9n","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"2024013019142650900_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-3476(85)80287-0","article-title":"Growth hormone secretory dynamics in Turner's syndrome","volume":"106","author":"Ross","year":"1985","journal-title":"J Pediatr"},{"key":"2024013019142650900_bib9","first-page":"861","article-title":"Turner syndrome adolescents receiving growth hormone are not osteopenic","volume":"76","author":"Neely","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019142650900_bib10","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.85.7.2307","article-title":"Enhanced osteoblast proliferation and collagen gene expression by estradiol","volume":"85","author":"Ernst","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019142650900_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.3164526","article-title":"Estrogenic binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells","volume":"241","author":"Komm","year":"1988","journal-title":"Science"},{"key":"2024013019142650900_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI115588","article-title":"Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation","volume":"89","author":"Chow","year":"1992","journal-title":"J Clin Invest"},{"key":"2024013019142650900_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"key":"2024013019142650900_bib14","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019142650900_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s001980050194","article-title":"Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy","volume":"10","author":"Vedi","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013019142650900_bib16","first-page":"289","article-title":"Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study","volume":"86","author":"Khastgir","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"2024013019142650900_bib17","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1507\/endocrj.47.SupplMarch_S115","article-title":"Bone mineral density in Turner syndrome: Relation to GH treatment and estrogen treatment","volume":"47","author":"Sato","year":"2000","journal-title":"Endocr J"},{"key":"2024013019142650900_bib18","first-page":"747","article-title":"Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome","volume":"79","author":"Mora","year":"1992","journal-title":"Obstet Gynaecol"},{"key":"2024013019142650900_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024013019142650900_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jbmr.5650040210","article-title":"Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome","volume":"4","author":"Stepan","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024013019142650900_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","article-title":"Morbidity in Turner syndrome","volume":"51","author":"Gravholt","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2024013019142650900_bib22","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1073\/pnas.87.6.2172","article-title":"Direct effects of 17\u03b2-estradiol on trabecular bone in ovariectomised rats","volume":"87","author":"Takano-Yamamoto","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019142650900_bib23","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1210\/endo.130.5.1572310","article-title":"17\u03b2\u2212estradiol stimulates cancellous bone formation in female rats","volume":"130","author":"Chow","year":"1992","journal-title":"Endocrinology"},{"key":"2024013019142650900_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00316876","article-title":"Minimal levels of serum estradiol prevent postmenopausal bone loss","volume":"51","author":"Reginster","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"2024013019142650900_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1359\/jbmr.1999.14.4.609","article-title":"Changes in bone resorption during the menstrual cycle","volume":"14","author":"Chiu","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019142650900_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0022-3476(74)80755-9","article-title":"Osteoporosis in ovarian dysgenesis","volume":"84","author":"Brown","year":"1974","journal-title":"J Pediatr"},{"key":"2024013019142650900_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1359\/jbmr.1998.13.8.1243","article-title":"The role of estrogen in the control of rat osteocyte apoptosis","volume":"13","author":"Tomkinson","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024013019142650900_bib28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"Suppl","key":"2024013019142650900_bib29","first-page":"97","article-title":"Bidirectional response of rat osteoclasts to 17\u03b2-estradiol","volume":"123","author":"Tobias","year":"1989","journal-title":"J Endocrinol"},{"key":"2024013019142650900_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1469-7580.1999.19430407.x","article-title":"The impact of mammalian reproduction on cancellous bone architecture","volume":"194","author":"Shahtaheri","year":"1999","journal-title":"J Anat"},{"key":"2024013019142650900_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S8756-3282(01)00643-3","article-title":"Deletion of estrogen receptors reveals a regulatory role for estrogen receptor-\u03b2 in bone remodelling in females but not in males","volume":"30","author":"Sims","year":"2002","journal-title":"Bone"},{"key":"2024013019142650900_bib32","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1210\/endo.140.12.7179","article-title":"The estrogen receptor beta-isoform (ER beta) of the human estrogen receptor modules ER alpha transcriptional activity and is a key regulator of the cellular responses to estrogens and antiestrogens","volume":"140","author":"Hall","year":"1999","journal-title":"Endocrinology"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2003.18.5.925","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/18\/5\/925\/56470273\/5650180517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/18\/5\/925\/56470273\/5650180517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:07:05Z","timestamp":1710342425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/18\/5\/925-932\/7592405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2003,5,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2003.18.5.925","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,5,1]]},"published":{"date-parts":[[2003,5,1]]}}}